Tag Archive | "InMedica"

Affordable Care Act Expected to Boost mHealth Patient Monitoring


Thousands of additional cardiac patients will be monitored via mHealth and remote monitoring tools before the close of the decade.

InMedica, a division of IMS Research, projects that at-home health monitoring will spike sixfold by 2017.

In 2012, clinicians reviewed long-distance vital signs on computer screens for some 227 000 patients with congestive heart failure (CHF), hypertension, diabetes, chronic obstructive pulmonary disease (COPD), and mental illness.

Read the full story

Posted in TechnologyComments (0)

Mobile Monitoring for Cardiac Patients on the Rise


Individuals suffering from congestive heart failure (CHF) are becoming exceptional candidates for mobile health monitoring solutions.

According to the latest insight from InMedica, there was estimated to be 308,000 patients remotely monitored by their healthcare provider for CHF and other conditions worldwide last year. The majority of these monitored individuals, however, were “post-acute” patients and been previously hospitalized and discharged.

InMedica says that CHF currently accounts for the majority of telehealth patients, in addition to being “one of the largest cost-burdens for hospitalization.”

Read the full story

Posted in TechnologyComments (0)

Telehealth Revenue to Reach $990M by 2015


Medical research firm InMedica has released a new whitepaper detailing the increased growth and adoption in telemedicine — an industry that’s forecast to produce more than 990M in revenues by 2015.

The whitepaper, entitled “Competitive Dynamics in the World Telehealth Market – 2011 to 2020,” looks at the telehealth market over the next 10 years and covers what it calls the “major parts of the ecosystem,” which include peripheral device suppliers – blood pressure monitors, glucose meters etc; gateway suppliers – health hubs and mobile gateways; and data transmission service providers – POTS, cellular and broadband.

Read the full story

Posted in TechnologyComments (0)


Advert